Hepatitis A
📧 Sign up to get email alerts when something new happens for Hepatitis A.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis [NA]
This clinical trial compares oral ursodeoxycholic acid for reducing bilirubin levels in patients with acute viral hepatitis and is currently…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis
This clinical trial evaluates hepatitis A immunity and the immunogenicity of a single-dose HAV vaccine in patients with cirrhosis; the study…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents
Clinical trial update on the long-term immunogenicity of the L-HAV Hepatitis A vaccine in healthy Thai children and adolescents. The study s…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV [Phase 3]
This Phase 3 clinical trial update describes the immunogenicity and safety evaluation of the investigational hepatitis A vaccine I-HAV in he…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
A prospective cohort study investigating immune checkpoint inhibitor–induced hepatitis in cancer patients; currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)
Clinical trial protocol update for Access Anti-HAV and Access Anti-HAV IgM assays in Europe (HAV-EU-11-23) sponsored by Beckman Coulter; the…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Phase IV Study of Concomitant Administration of the sIPV and HepA [Phase 4]
Phase IV trial update evaluating concomitant administration of Sabin Inactivated Poliovirus Vaccine (sIPV) and Hepatitis A vaccine; status i…
-
CLINICAL_TRIALS research · 2023-12-28Clinical Trial Update: Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination. [Phase 4]
A Phase 4 clinical trial update reports on the persistence of hepatitis A antibody in healthy adults roughly 32 years after vaccination.
-
CLINICAL_TRIALS research · 2023-10-10Clinical Trial Update: The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines [Phase 4]
Phase 4 trial assessing immunogenicity and safety of inactivated and live attenuated Hepatitis A vaccines.
-
CLINICAL_TRIALS research · 2019-09-23Clinical Trial Update: This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama [NA]
A completed clinical trial assessing long-term persistence of Hepatitis A antibodies in children after Havrix vaccination in Panama, with re…
-
CLINICAL_TRIALS research · 2012-11-22Clinical Trial Update: Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children
Completed surveillance study sponsored by GlaxoSmithKline to determine trends in Acute Hepatitis A among Panamanian children. The study rela…
-
CLINICAL_TRIALS research · 2011-01-13Clinical Trial Update: Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult [Phase 4]
Phase 4 trial assessing antibody persistence and immune memory in healthy adults previously vaccinated with Twinrix Adult.